Search Results 511-520 of 17192 for remdesivir

  1. Capivasertib (oral route) - Side effects & dosage - Mayo Clinic

    Capivasertib is used in combination with fulvestrant to treat HR-positive, HER-2 negative breast cancer that is advanced or metastatic (cancer that has spread) ...

  2. Clinical trials - Oncology (Medical)

    This trial studies how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian ...

  3. Clinical trials - Oncology (Medical)

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  4. COlorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo‑Controlled Phase-III STudy - Mayo Clinic

    About this study. To evaluate and compare the efficacy and safety of regorafenib versus placebo in subjects with colorectal cancer (CRC) after curative ...

  5. https://www.mayoclinic.org/arabic_condition_consolidated_concepts.xml

  6. Neurology - Clinical trials - Mayo Clinic

    The purpose of this study is to develop prognostic and diagnostic blood tests for symptomatic brain hemorrhage in patients diagnosed with cavernous angiomas ...

  7. Clinical trials - Oncology (Medical)

    The goal of this clinical trial is to learn about the safety of drug \[Ac225\]RTX-2358 and the diagnostic imaging agent \[Cu64\]LNTH-1363S.

  8. A Study with to Assess the Effectiveness and Safety of Selexipag as Standard-of-Care Add-on in Subjects with Inoperable or Persistent/Recurrent After-surgical Treatment CTEPH - Mayo Clinic

    A Study with to Assess the Effectiveness and Safety of Selexipag as Standard-of-Care Add-on in Subjects with Inoperable or Persistent/Recurrent After-surgical ...

  9. Clinical trials - Oncology (Medical)

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

  10. Cosibelimab-ipdl (intravenous route) - Side effects & uses - Mayo Clinic

    Cosibelimab-ipdl injection is used to treat a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread (metastatic or locally ...